Δημοσίευση

Platelet Mass Predicts Intracranial Hemorrhage in Neonates With Gram-negative Sepsis.

ΤίτλοςPlatelet Mass Predicts Intracranial Hemorrhage in Neonates With Gram-negative Sepsis.
Publication TypeJournal Article
Year of Publication2015
AuthorsMitsiakos, G., Pana Z-D., Chatziioannidis I., Piltsouli D., Lazaridou E., Koulourida V., Papadimitriou A., Nikolaidis N., & Roilides E.
JournalJ Pediatr Hematol Oncol
Volume37
Issue7
Pagination519-23
Date Published2015 Oct
ISSN1536-3678
Λέξεις κλειδιάArea Under Curve, Blood Platelets, Female, Gram-Negative Bacterial Infections, Humans, Infant, Newborn, Infant, Newborn, Diseases, Intracranial Hemorrhages, Male, Platelet Count, ROC Curve, Sepsis
Abstract

Neonatal sepsis due to gram-negative bacteria is associated with severe hemorrhagic conditions, such as intracranial hemorrhage (ICH). The aim of the study was to investigate the significance of platelet (PLT) count and platelet mass (PM) in predicting promptly neonatal ICH. Demographics, species, PLT, PM, ICH, and outcome for neonates with gram-negative sepsis for the period 2005 to 2012 were retrospectively recorded. Eighty-four infants were enrolled with median gestational age 30 weeks, median birthweight 1481.5 g, and median age at sepsis diagnosis 23 days. The most frequently isolated bacteria were Enterobacter spp. (38.1%). ICH occurred in 16 neonates (19%), whereas the mortality rate was 25% (21 neonates). The median PLT count and PM at days 1, 2, and 3 after diagnosis of gram-negative sepsis was significantly associated with the presence of ICH. Regression analysis revealed the cutoff predictive value of 355 fL/nL for the PM at day 3 (area under the curve: 75, sensitivity 90%, P=0.002). PM levels could play an important role in predicting the occurrence of ICH in high-risk neonates.

DOI10.1097/MPH.0000000000000367
Alternate JournalJ Pediatr Hematol Oncol
PubMed ID26376234

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.